Prevalence and sociodemographic correlates of antinuclear antibody testing by indirect immunofluorescence or solid-phase assays in a Spanish population: the Camargo Cohort

Autoantibodies are the hallmark of autoimmunity, and specifically, antinuclear antibodies (ANA) are one of the most relevant antibodies present in systemic autoimmune diseases (AID). In the present study, we evaluate the relationship between ANA and sociodemographic and biobehavioral factors in a po...

Full description

Saved in:
Bibliographic Details
Published in:Immunologic research 2024-04, Vol.72 (2), p.260-270
Main Authors: Irure-Ventura, Juan, Martínez-Revuelta, Daniel, López-Hoyos, Marcos, Martín-Millán, Marta, Nan, Daniel, Pariente, Emilio, Pardo-Lledías, Javier, Comins-Boo, Alejandra, Olmos, José Manuel, Martínez-Taboada, Víctor Manuel, Hernández, José Luis
Format: Article
Language:English
Subjects:
Allergology
Antibodies
Antibodies, Antinuclear
Antinuclear antibodies
Autoantibodies
Autoimmune diseases
Autoimmune Diseases - diagnosis
Autoimmune Diseases - epidemiology
Autoimmunity
Biomedical and Life Sciences
Biomedicine
C-reactive protein
Enzyme immunoassay
Female
Females
Fluorescent Antibody Technique, Indirect - methods
Humans
Immunoassay
Immunoassay - methods
Immunofluorescence
Immunology
Internal Medicine
Medicine/Public Health
Original
Original Article
Prevalence
Sex differences
Sociodemographics
Solid phases
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Autoantibodies are the hallmark of autoimmunity, and specifically, antinuclear antibodies (ANA) are one of the most relevant antibodies present in systemic autoimmune diseases (AID). In the present study, we evaluate the relationship between ANA and sociodemographic and biobehavioral factors in a population with a low pre-test probability for systemic AID. ANA were determined in serum samples at baseline visit from 2997 participants from the Camargo Cohort using indirect immunofluorescence assay, and two solid phase assays (SPA), addressable laser bead immunoassay, and fluorescence enzyme immunoassay. Sociodemographic and biobehavioral features of the subjects were obtained at baseline visit using a structured questionnaire. The prevalence of ANA positive results was significantly higher when indirect immunofluorescence assay was used as screening method in comparison with SPAs, being higher in females, older subjects, and those with higher C-reactive protein levels. Considering biobehavioral features, the prevalence was higher in those individuals with a sedentary lifestyle, and in ex- and non-alcohol users. Moreover, considering the relevance of the antibody load using ANA Screen, the prevalence of the antibody load also increased with age, especially in females. In conclusion, the prevalence of ANA varies depending on sociodemographic and biobehavioral features of the subjects, which could be relevant specifically in a population with a low pre-test probability for systemic AIDs.
ISSN:0257-277X
1559-0755
DOI:10.1007/s12026-023-09430-z